Bisected, complex N-glycans and galectins in mouse mammary tumor progression and human breast cancer

Hazuki E. Miwa, Wade R. Koba, Eugene J. Fine, Orsolya Giricz, Paraic A. Kenny, Pamela Stanley

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Bisected, complex N-glycans on glycoproteins are generated by the glycosyltransferase MGAT3 and cause reduced cell surface binding of galectins. Previously, we showed that MGAT3 reduces growth factor signaling and retards mammary tumor progression driven by the Polyoma middle T antigen (PyMT) expressed in mammary epithelium under the mouse mammary tumor virus (MMTV) promoter. However, the penetrance of the tumor phenotype became variable in mixed FVB/N and C57BL/6 female mice and we therefore investigated a congenic C57BL/6 Mgat3-/-/MMTV-PyMT model. In the absence of MGAT3, C57BL/6 Mgat3-/-/MMTV-PyMT females exhibited accelerated tumor appearance and increased tumor burden, glucose uptake in tumors and lung metastasis. Nevertheless, activation of extracellular signal-regulated kinase (ERK)1/2 or protein kinase B (AKT) was reduced in ∼20-week C57BL/6 MMTV-PyMT tumors lacking MGAT3. Activation of focal adhesion kinase (FAK), protein tyrosine kinase Src, and p38 mitogen-activated protein kinase were similar to that of controls. All the eight mouse galectin genes were expressed in mammary tumors and tumor epithelial cells (TECs), but galectin-2 and -12 were not detected by western analysis in tumors, and galectin-7 was not detected in 60% of the TEC lines. From microarray data reported for human breast cancers, at least 10 galectin and 7 N-glycan N-acetylglucosaminyl (GlcNAc)-transferase (MGAT) genes are expressed in tumor tissue, and expression often varies significantly between different breast cancer subtypes. Thus, in summary, while MGAT3 and bisected complex N-glycans retard mouse mammary tumor progression, genetic background may modify this effect; identification of key galectins that promote mammary tumor progression in mice is not straightforward because all the eight galectin genes are expressed; and high levels of MGAT3, galectin-4, -8, -10, -13 and -14 transcripts correlate with better relapse-free survival in human breast cancer.

Original languageEnglish (US)
Pages (from-to)1477-1490
Number of pages14
JournalGlycobiology
Volume23
Issue number12
DOIs
StatePublished - Dec 2013

Fingerprint

Galectins
Polysaccharides
Tumors
Mouse mammary tumor virus
Breast Neoplasms
Viral Tumor Antigens
Neoplasms
Galectin 2
Galectin 4
Viruses
Epithelial Cells
Genes
Focal Adhesion Protein-Tyrosine Kinases
Proto-Oncogene Proteins c-akt
Mitogen-Activated Protein Kinase 3
src-Family Kinases
Penetrance
Mitogen-Activated Protein Kinase 1
p38 Mitogen-Activated Protein Kinases
Transferases

Keywords

  • Breast cancer
  • Galectins
  • Mammary tumors
  • MGAT3/TCGA

ASJC Scopus subject areas

  • Biochemistry

Cite this

Bisected, complex N-glycans and galectins in mouse mammary tumor progression and human breast cancer. / Miwa, Hazuki E.; Koba, Wade R.; Fine, Eugene J.; Giricz, Orsolya; Kenny, Paraic A.; Stanley, Pamela.

In: Glycobiology, Vol. 23, No. 12, 12.2013, p. 1477-1490.

Research output: Contribution to journalArticle

Miwa, Hazuki E. ; Koba, Wade R. ; Fine, Eugene J. ; Giricz, Orsolya ; Kenny, Paraic A. ; Stanley, Pamela. / Bisected, complex N-glycans and galectins in mouse mammary tumor progression and human breast cancer. In: Glycobiology. 2013 ; Vol. 23, No. 12. pp. 1477-1490.
@article{5e535b206b47449c837faa071adbb25d,
title = "Bisected, complex N-glycans and galectins in mouse mammary tumor progression and human breast cancer",
abstract = "Bisected, complex N-glycans on glycoproteins are generated by the glycosyltransferase MGAT3 and cause reduced cell surface binding of galectins. Previously, we showed that MGAT3 reduces growth factor signaling and retards mammary tumor progression driven by the Polyoma middle T antigen (PyMT) expressed in mammary epithelium under the mouse mammary tumor virus (MMTV) promoter. However, the penetrance of the tumor phenotype became variable in mixed FVB/N and C57BL/6 female mice and we therefore investigated a congenic C57BL/6 Mgat3-/-/MMTV-PyMT model. In the absence of MGAT3, C57BL/6 Mgat3-/-/MMTV-PyMT females exhibited accelerated tumor appearance and increased tumor burden, glucose uptake in tumors and lung metastasis. Nevertheless, activation of extracellular signal-regulated kinase (ERK)1/2 or protein kinase B (AKT) was reduced in ∼20-week C57BL/6 MMTV-PyMT tumors lacking MGAT3. Activation of focal adhesion kinase (FAK), protein tyrosine kinase Src, and p38 mitogen-activated protein kinase were similar to that of controls. All the eight mouse galectin genes were expressed in mammary tumors and tumor epithelial cells (TECs), but galectin-2 and -12 were not detected by western analysis in tumors, and galectin-7 was not detected in 60{\%} of the TEC lines. From microarray data reported for human breast cancers, at least 10 galectin and 7 N-glycan N-acetylglucosaminyl (GlcNAc)-transferase (MGAT) genes are expressed in tumor tissue, and expression often varies significantly between different breast cancer subtypes. Thus, in summary, while MGAT3 and bisected complex N-glycans retard mouse mammary tumor progression, genetic background may modify this effect; identification of key galectins that promote mammary tumor progression in mice is not straightforward because all the eight galectin genes are expressed; and high levels of MGAT3, galectin-4, -8, -10, -13 and -14 transcripts correlate with better relapse-free survival in human breast cancer.",
keywords = "Breast cancer, Galectins, Mammary tumors, MGAT3/TCGA",
author = "Miwa, {Hazuki E.} and Koba, {Wade R.} and Fine, {Eugene J.} and Orsolya Giricz and Kenny, {Paraic A.} and Pamela Stanley",
year = "2013",
month = "12",
doi = "10.1093/glycob/cwt075",
language = "English (US)",
volume = "23",
pages = "1477--1490",
journal = "Glycobiology",
issn = "0959-6658",
publisher = "Oxford University Press",
number = "12",

}

TY - JOUR

T1 - Bisected, complex N-glycans and galectins in mouse mammary tumor progression and human breast cancer

AU - Miwa, Hazuki E.

AU - Koba, Wade R.

AU - Fine, Eugene J.

AU - Giricz, Orsolya

AU - Kenny, Paraic A.

AU - Stanley, Pamela

PY - 2013/12

Y1 - 2013/12

N2 - Bisected, complex N-glycans on glycoproteins are generated by the glycosyltransferase MGAT3 and cause reduced cell surface binding of galectins. Previously, we showed that MGAT3 reduces growth factor signaling and retards mammary tumor progression driven by the Polyoma middle T antigen (PyMT) expressed in mammary epithelium under the mouse mammary tumor virus (MMTV) promoter. However, the penetrance of the tumor phenotype became variable in mixed FVB/N and C57BL/6 female mice and we therefore investigated a congenic C57BL/6 Mgat3-/-/MMTV-PyMT model. In the absence of MGAT3, C57BL/6 Mgat3-/-/MMTV-PyMT females exhibited accelerated tumor appearance and increased tumor burden, glucose uptake in tumors and lung metastasis. Nevertheless, activation of extracellular signal-regulated kinase (ERK)1/2 or protein kinase B (AKT) was reduced in ∼20-week C57BL/6 MMTV-PyMT tumors lacking MGAT3. Activation of focal adhesion kinase (FAK), protein tyrosine kinase Src, and p38 mitogen-activated protein kinase were similar to that of controls. All the eight mouse galectin genes were expressed in mammary tumors and tumor epithelial cells (TECs), but galectin-2 and -12 were not detected by western analysis in tumors, and galectin-7 was not detected in 60% of the TEC lines. From microarray data reported for human breast cancers, at least 10 galectin and 7 N-glycan N-acetylglucosaminyl (GlcNAc)-transferase (MGAT) genes are expressed in tumor tissue, and expression often varies significantly between different breast cancer subtypes. Thus, in summary, while MGAT3 and bisected complex N-glycans retard mouse mammary tumor progression, genetic background may modify this effect; identification of key galectins that promote mammary tumor progression in mice is not straightforward because all the eight galectin genes are expressed; and high levels of MGAT3, galectin-4, -8, -10, -13 and -14 transcripts correlate with better relapse-free survival in human breast cancer.

AB - Bisected, complex N-glycans on glycoproteins are generated by the glycosyltransferase MGAT3 and cause reduced cell surface binding of galectins. Previously, we showed that MGAT3 reduces growth factor signaling and retards mammary tumor progression driven by the Polyoma middle T antigen (PyMT) expressed in mammary epithelium under the mouse mammary tumor virus (MMTV) promoter. However, the penetrance of the tumor phenotype became variable in mixed FVB/N and C57BL/6 female mice and we therefore investigated a congenic C57BL/6 Mgat3-/-/MMTV-PyMT model. In the absence of MGAT3, C57BL/6 Mgat3-/-/MMTV-PyMT females exhibited accelerated tumor appearance and increased tumor burden, glucose uptake in tumors and lung metastasis. Nevertheless, activation of extracellular signal-regulated kinase (ERK)1/2 or protein kinase B (AKT) was reduced in ∼20-week C57BL/6 MMTV-PyMT tumors lacking MGAT3. Activation of focal adhesion kinase (FAK), protein tyrosine kinase Src, and p38 mitogen-activated protein kinase were similar to that of controls. All the eight mouse galectin genes were expressed in mammary tumors and tumor epithelial cells (TECs), but galectin-2 and -12 were not detected by western analysis in tumors, and galectin-7 was not detected in 60% of the TEC lines. From microarray data reported for human breast cancers, at least 10 galectin and 7 N-glycan N-acetylglucosaminyl (GlcNAc)-transferase (MGAT) genes are expressed in tumor tissue, and expression often varies significantly between different breast cancer subtypes. Thus, in summary, while MGAT3 and bisected complex N-glycans retard mouse mammary tumor progression, genetic background may modify this effect; identification of key galectins that promote mammary tumor progression in mice is not straightforward because all the eight galectin genes are expressed; and high levels of MGAT3, galectin-4, -8, -10, -13 and -14 transcripts correlate with better relapse-free survival in human breast cancer.

KW - Breast cancer

KW - Galectins

KW - Mammary tumors

KW - MGAT3/TCGA

UR - http://www.scopus.com/inward/record.url?scp=84887914597&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887914597&partnerID=8YFLogxK

U2 - 10.1093/glycob/cwt075

DO - 10.1093/glycob/cwt075

M3 - Article

C2 - 24037315

AN - SCOPUS:84887914597

VL - 23

SP - 1477

EP - 1490

JO - Glycobiology

JF - Glycobiology

SN - 0959-6658

IS - 12

ER -